Remove Genetic Engineering Remove Protein Remove Scientist
article thumbnail

AI-designed serotonin tracker could help develop neurology drugs

pharmaphorum

A serotonin sensor designed using Artificial Intelligence (AI) could help scientists study sleep and mental health and potentially find new neurology drugs. The US National Institutes of Health said that the research it had co-funded used AI to transform a bacterial protein into a new research tool.

article thumbnail

Precision Fermentation Study May Revolutionize Food Quality and Sustainability

XTalks

By genetically editing microorganisms, scientists can now manipulate the metabolic pathways to produce foods with desirable properties. The precision fermentation study highlights how genetically engineered microorganisms can inhibit the growth of foodborne pathogens.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The New Frontier in Drug Development: Understanding Biologics and Small Molecules

Cloudbyz

Biologics: Biologics are large, complex molecules, often proteins, that are produced using living cells. Mode of Action : Small Molecules: They often work by binding to specific sites on target proteins to inhibit or activate their function, which can affect various biological pathways inside the cell.

article thumbnail

Blocking enzyme could hold the key to preventing, treating severe COVID-19

The Pharma Data

Scientists who have long studied this molecule’s functions in bacterial infections traced development of extensive lung damage in infected mice to heightened levels of the enzyme triggered by the invading SARS-CoV-2 virus. They used a version of the SARS-CoV-2 virus that other scientists have engineered specifically to cause disease in mice.

article thumbnail

Elasmogen announces a panel of novel, potent, anti-COVID-19 therapeutic candidates identified through collaboration with U.S. research partners

The Pharma Data

25, 2021 /PRNewswire/ — Elasmogen Ltd , the pioneering biopharmaceutical company leading the development of VNAR and soloMER biologics, today announces a significant breakthrough in the identification of next-generation protein-based drugs potentially capable of stopping COVID-19 infections. ABERDEEN, Scotland , Jan.

article thumbnail

Pfizer/BioNTech COVID jab works against Brazil variant; lab study

pharmaphorum

The study suggests that serum taken from patients injected with the mRNA shot, also known as BNT162b2, was able to neutralise a genetically engineered version of SARS-CoV-2 with the P.1 1 mutations, as well as variants from the UK and South Africa.

article thumbnail

How Biden’s New Biotechnology and Biomanufacturing Executive Order Will Impact the Future of Food

XTalks

The US Food and Drug Administration (FDA) approved the first genetically engineered crops nearly 30 years ago with the Rainbow papaya — created with an immunity to a virus that threatened to decimate the crop — and the Flavr Savr tomato. Biotechnology is also taking on new forms in food. GMO and Bioengineering Controversy.